Mostrar el registro sencillo del ítem

dc.contributor.authorCalviño-Sampedro, C.
dc.contributor.authorGomez-Tourino, I.
dc.contributor.authorCordero, O. J.
dc.contributor.authorReche, P. A.
dc.contributor.authorGómez-Perosanz, M.
dc.contributor.authorSánchez-Trincado, J. L.
dc.contributor.authorRodríguez, M. Á
dc.contributor.authorMartís Sueiro, Aurelio Manuel
dc.contributor.authorViñuela Roldán, Juan 
dc.contributor.authorCalviño, R. V.
dc.date.accessioned2021-11-30T09:33:25Z
dc.date.available2021-11-30T09:33:25Z
dc.date.issued2019
dc.identifier.issn0892-6638
dc.identifier.otherhttps://www.ncbi.nlm.nih.gov/pubmed/30817223es
dc.identifier.urihttp://hdl.handle.net/20.500.11940/15757
dc.description.abstractType 1 diabetes (T1D) results from the destruction of pancreatic beta-cells by the immune system, and CD8(+) T lymphocytes are critical actors in this autoimmune response. Pancreatic islets are surrounded by a mesh of nervous cells, the peri-insular Schwann cells, which are also targeted by autoreactive T lymphocytes and express specific antigens, such as the neurotrophic factor S100-beta. Previous work has shown increased proliferative responses to whole S100-beta in both human T1D patients and the nonobese diabetic (NOD) mouse model. We describe for the first time naturally processed and presented epitopes (NPPEs) presented by class I human leukocyte antigen-A*02:01 (A2.1) molecules derived from S100-beta. These NPPEs triggered IFN-gamma responses more frequently in both newly diagnosed and long-term T1D patients compared with healthy donors. Furthermore, the same NPPEs are recognized during the autoimmune response leading to diabetes in A2.1-transgenic NOD mice as early as 4 wk of age. Interestingly, when these NPPEs are used to prevent diabetes in this animal model, an acceleration of the disease is observed together with an exacerbation in insulitis and an increase in S100-beta-specific cytotoxicity in vaccinated animals. Whether these can be used in diabetes prevention needs to be carefully evaluated in animal models before use in future clinical assays.-Calvino-Sampedro, C., Gomez-Tourino, I., Cordero, O. J., Reche, P. A., Gomez-Perosanz, M., Sanchez-Trincado, J. L., Rodriguez, M. A., Sueiro, A. M., Vinuela, J. E., Calvino, R. V. Naturally presented HLA class I-restricted epitopes from the neurotrophic factor S100-beta are targets of the autoimmune response in type 1 diabetes.en
dc.language.isoenges
dc.rightsAtribución 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subject.meshEpitopes*
dc.subject.meshHumans*
dc.subject.meshHLA-A2 Antigen*
dc.subject.meshMice*
dc.subject.meshInterferon-gamma*
dc.subject.meshDiabetes Mellitus*
dc.subject.meshAnimals*
dc.subject.meshK562 Cells*
dc.subject.meshS100 Calcium Binding Protein beta Subunit*
dc.titleNaturally presented HLA class I-restricted epitopes from the neurotrophic factor S100-β are targets of the autoimmune response in type 1 diabetesen
dc.typeArtigoes
dc.authorsophosCalviño-Sampedro, C.
dc.authorsophosGomez-Tourino, I.
dc.authorsophosCordero, O. J.
dc.authorsophosReche, P. A.
dc.authorsophosGómez-Perosanz, M.
dc.authorsophosSánchez-Trincado, J. L.
dc.authorsophosRodríguez, M. Á
dc.authorsophosSueiro, A. M.
dc.authorsophosViñuela, J. E.
dc.authorsophosCalviño, R. V.
dc.identifier.doi10.1096/fj.201802270R
dc.identifier.pmid30817223
dc.identifier.sophos31700
dc.issue.number5es
dc.journal.titleFASEB JOURNALes
dc.organizationServizo Galego de Saúde::Estrutura de Xestión Integrada (EOXI)::EOXI de Santiago de Compostela - Complexo Hospitalario Universitario de Santiago de Compostela::Análise clínicoses
dc.organizationServizo Galego de Saúde::Estrutura de Xestión Integrada (EOXI)::EOXI de Santiago de Compostela - Complexo Hospitalario Universitario de Santiago de Compostela::Endocrinoloxíaes
dc.page.initial6390es
dc.page.final6401es
dc.relation.publisherversionhttps://faseb.onlinelibrary.wiley.com/doi/pdfdirect/10.1096/fj.201802270R?download=truees
dc.rights.accessRightsopenAccesses
dc.subject.decsanimales*
dc.subject.decsantígeno HLA-A2*
dc.subject.decssubunidad beta de la proteína de unión al calcio S100*
dc.subject.decscélulas K562*
dc.subject.decshumanos*
dc.subject.decsepítopos*
dc.subject.decsdiabetes mellitus*
dc.subject.decsratones*
dc.subject.decsinterferón gamma*
dc.subject.keywordCHUSes
dc.typefidesArtículo Originales
dc.typesophosArtículo Originales
dc.volume.number33es


Ficheros en el ítem

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Atribución 4.0 Internacional
Excepto si se señala otra cosa, la licencia del ítem se describe como Atribución 4.0 Internacional